BioIntelliSense
Healthcare Software · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17301 W Colfax Ave Ste 152, Golden, Colo...Phone Number
(720) 689-9008Website
www.biointellisense.comRevenue
$7.8 MillionIndustry
About BioIntelliSense
BioIntelliSense Org Chart
Is BioIntelliSense your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioIntelliSense is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at BioIntelliSense
Website visits: Recent activity has been detected on your website
BioIntelliSense, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on BioIntelliSense recently announced quarterly report
Product Launch: Get notified when BioIntelliSense launches new products
Check if BioIntelliSense has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BioIntelliSense has new funding data
Click to see if BioIntelliSense had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BioIntelliSense
Compare insights from companies similar to BioIntelliSense, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioIntelliSense
Company Profile Activity
Activity Insights
BioIntelliSense is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
BioIntelliSense is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about BioIntelliSense.
BioIntelliSense financials insights
Gather financial insights about BioIntelliSense, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$25M
Series B
$45M
BioIntelliSense Tech Stack
A closer look at the technologies used by BioIntelliSense
Most Recent Scoops
BioIntelliSense News & Media
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine ... - Silicon UK
All IT news on Silicon.co.ukBioIntelliSense Announces Observational Study in Journal of Clinical Medicine Demonstrating Early Detection of Patient Deterioration with FDA-cleared BioButton® Continuous Monitoring Wearable Device
DENVER--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced publication of peer-reviewed research in the Journal of Clinical Medicine titled, “A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients.” This study, which was conducted over 15 months in the medical-surgical units of two U.S. hospitals, highlights the transformative potential ofBioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™ System for Continuous Patient Monitoring
DENVER--(BUSINESS WIRE)--BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs. The BioButton Multi-Patient medical device expands the BioIntelliSense award-winning portfolio of continuous patient monitoring solutions by offering a rechargeable and reusable inpatient solution for automating vital sigiRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM) market iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM) market
Top Healthcare Software Companies
Frequently Asked Questions Regarding BioIntelliSense
BioIntelliSense offers health monitoring and clinical intelligence solutions. Its medical-grade Data-as-a-Service (DaaS) platform captures vital signs, physiological biometrics and symptomatic events through an wearable body sensor. BioIntelliSense is based in Redwood City, CA.... Read More